THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

James George to Drug Therapy, Combination

This is a "connection" page, showing publications James George has written about Drug Therapy, Combination.
Connection Strength

0.474
  1. Management of patients with chronic, refractory idiopathic thrombocytopenic purpura. Semin Hematol. 2000 Jul; 37(3):290-8.
    View in: PubMed
    Score: 0.169
  2. Caplacizumab Therapy without Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura. N Engl J Med. 2019 07 04; 381(1):92-94.
    View in: PubMed
    Score: 0.157
  3. Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura. Int J Hematol. 2005 Feb; 81(2):119-25.
    View in: PubMed
    Score: 0.058
  4. Thrombotic thrombocytopenic purpura: from the bench to the bedside, but not yet to the community. Ann Intern Med. 2003 Jan 21; 138(2):152-3.
    View in: PubMed
    Score: 0.050
  5. Acquired pure megakaryocytic aplasia report of two cases with long-term responses to antithymocyte globulin and cyclosporine. Am J Hematol. 1999 Oct; 62(2):115-7.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES